CURRENT STUDIES ON THE EFFECT ANTIMETABOLITES IN NEPHROSIS, OTHER NON-NEOPLASTIC DISEASES, AND EXPERIMENTAL ANIMALS. COMBINED CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH.
D000361:Agammaglobulinemia; D000410:Alanine Transaminase; D000818:Animals; D000963:Antimetabolites; D001327:Autoimmune Diseases; D004796:Clinical Enzyme Tests; D004679:Encephalomyelitis; D006505:Hepatitis; D006967:Hypersensitivity; D008180:Lupus Erythematosus, Systemic; D015122:Mercaptopurine; D009316:National Institutes of Health (U.S.); D009401:Nephrosis; D009404:Nephrotic Syndrome; D011241:Prednisone; D012882:Skin Tests; D014481:United States
D000963:Antimetabolites; D015122:Mercaptopurine; D000410:Alanine Transaminase; D011241:Prednisone
AGAMMAGLOBULINEMIA; ALANINE AMINOTRANSFERASE; ANTIMETABOLITES; AUTOIMMUNE DISEASES; ENCEPHALOMYELITIS; ENZYME TESTS; HEPATITIS; HYPERSENSITIVITY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MERCAPTOPURINE; NEPHROSIS; NEPHROTIC SYNDROME; PREDNISONE; SKIN TESTS